Ujedinjeni Arapski Emirati - engleski - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

30 sachets -

Europska Unija - engleski - EMA (European Medicines Agency)

mylan s.a.s. - lopinavir/ritonavir - hiv infections - antivirals for systemic use, - lopinavir/ritonavir is indicated in combination with other antiretroviral medicinal products for the treatment of human immunodeficiency virus (hiv-1) infected adults, adolescents and children above the age of 2 years.the choice of lopinavir/ritonavir to treat protease inhibitor experienced hiv-1 infected patients should be based on individual viral resistance testing and treatment history of patients.

Australija - engleski - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - clofibrate, quantity: 500 mg - capsule, soft - excipient ingredients: glycerol; sorbitol; sodium propyl hydroxybenzoate; gelatin; sodium ethyl hydroxybenzoate - this product accepted for registration as 'currently supplied' at the time of commencement of the act. updated pregnancy risk category was approved as specified in the letter of 1 july 1992 from dr b. varma. indicated treatment: 1. primary dysbetalipoprotinaemia (type iii hyperlipidaemia) that does not respond adequately to diet; and 2. adult patients with very high serum triglyceride levels (types iv and v hyperlipidaemia) who present a risk of abdominal pain and who do not respond adequately to a determined dietary effort to control them. patients with triglycerides in excess of 750mg per decilitre are likely to present such a risk. indications as at 15 june 1994: col is indicated for primary dysbetalipoproteinaemia (type iii hyperlipidaemia) that does not respond adequately to diet. col may also be considered for the treatment of adult patients with very high serum triglyceride levels (types iv and v hyperlipidaemia) who present a risk of abdominal pain and pancreatitis and who do not respond adequately t

Egipat - engleski - EDA (Egyptian Drug Authority)

t3a pharma - topical ointment - 0.05 gm

Velika Britanija - engleski - MHRA (Medicines & Healthcare Products Regulatory Agency)

takeda uk ltd - normal immunoglobulin human - powder and solvent for solution for injection - 5gram

Velika Britanija - engleski - MHRA (Medicines & Healthcare Products Regulatory Agency)

takeda uk ltd - normal immunoglobulin human - powder and solvent for solution for injection - 10gram

Velika Britanija - engleski - MHRA (Medicines & Healthcare Products Regulatory Agency)

baxter healthcare ltd - aprotinin - irrigation - 3000kallikrein inactivator unit/1ml